Crystalvue Medical Corporation (TPEX:6527)
Taiwan · Delayed Price · Currency is TWD 74.70
-0.30 (-0.40%)
Aug 19, 2026, 1:30 PM CST
Crystalvue Medical Market Cap
Crystalvue Medical has a market cap or net worth of 1.89 billion as of August 19, 2026. Its market cap has decreased by -14.63% in one year.
Market Cap
1.89B
Enterprise Value
1.85B
Revenue
874.21M
Ranking
n/a
PE Ratio
12.99
Stock Price
74.70
ChartMarket Cap Chart
Since April 29, 2015, Crystalvue Medical's market cap has increased from 1.04B to 1.89B, an increase of 82.41%. That is a compound annual growth rate of 5.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 1.89B | -1.84% |
| Dec 31, 2025 | 1.93B | -10.37% |
| Dec 30, 2024 | 2.15B | -1.77% |
| Dec 29, 2023 | 2.19B | 76.51% |
| Dec 30, 2022 | 1.24B | 8.45% |
| Dec 30, 2021 | 1.14B | -3.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bionime | 4.40B |
| SciVision Biotech | 3.71B |
| Maxigen Biotech | 3.61B |
| ICARES Medicus | 3.45B |
| Nang Kuang Pharmaceutical | 3.23B |
| Chi Sheng Pharma & Biotech | 1.79B |
| BenQ Medical Technology | 1.75B |
| Ttbio | 1.42B |